Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-02-23 @ 4:54 AM
Study NCT ID:
NCT05244551
Status:
RECRUITING
Last Update Posted:
2024-08-12
First Post:
2022-01-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors
Sponsor:
Abbisko Therapeutics Co, Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ABSK061-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None